{"entity":{"id":"efinia","kind":"drug","name":"Efinia","aka":[],"tldr":"Efinia is an experimental wearable device from EMBioSys, a tank top that sends a weak electric field into breast tumours at home. It is not FDA cleared.","summary":"Efinia is the investigational induced electric field (iEF) therapy garment of EMBioSys, designed for breast cancer treatment at home while patients wait for surgery. An NCI SBIR award to EMBioSys funds the CuRrEnT study of Efinia's electric field with capecitabine in triple-negative breast cancer with residual disease. No efficacy results have been published.","asOf":"2026-11-04","links":[{"label":"EMBioSys: Efinia","url":"https://embiosys.com/our-therapy"},{"label":"NIH RePORTER: SBIR award 5R44CA310518-02","url":"https://reporter.nih.gov/project-details/11418087"}],"tags":["pipeline"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["embiosys"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo startup monitors","editedOn":"2026-11-04"},"modality":"Wearable induced electric field device","mechanism":"A tank-top garment with a battery-powered module delivers a low-intensity induced electric field to the breast, without electrodes or heating, as the developer describes.","approvals":[],"mechanismSteps":[],"toxicity":[],"access":[],"regulatoryEvents":[]},"route":"/drugs/efinia/","neighbours":{"company":[{"id":"embiosys","kind":"company","name":"EMBioSys","route":"/companies/embiosys/"}]}}